FBLN3 anticorps
-
- Antigène Voir toutes FBLN3 Anticorps
- FBLN3 (Fibulin 3 (FBLN3))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp FBLN3 est non-conjugé
-
Application
- Western Blotting (WB), Flow Cytometry (FACS)
- Attributs du produit
- Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 1
- Purification
- Purified from mouse ascites fluids by affinity chromatography
- Immunogène
- Full length human recombinant protein of human EFEMP1(NP_004096) produced in HEK293T cell.
- Clone
- 1D9
- Isotype
- IgG2a
- Top Product
- Discover our top product FBLN3 Anticorps primaire
-
-
- Indications d'application
- WB 1:200~500, FLOW 1:100,
- Commentaires
-
The concentration of the product may vary between diferrent lots.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
-
Fibulin-3 promotes muscle-invasive bladder cancer." dans: Oncogene, Vol. 36, Issue 37, pp. 5243-5251, (2017) (PubMed).
: "
-
Fibulin-3 promotes muscle-invasive bladder cancer." dans: Oncogene, Vol. 36, Issue 37, pp. 5243-5251, (2017) (PubMed).
-
- Antigène
- FBLN3 (Fibulin 3 (FBLN3))
- Autre désignation
- EFEMP1 (FBLN3 Produits)
- Synonymes
- anticorps DHRD, anticorps DRAD, anticorps FBLN3, anticorps FBNL, anticorps FIBL-3, anticorps MLVT, anticorps MTLV, anticorps S1-5, anticorps T16, anticorps EGF containing fibulin like extracellular matrix protein 1, anticorps EGF-containing fibulin-like extracellular matrix protein 1, anticorps epidermal growth factor-containing fibulin-like extracellular matrix protein 1, anticorps EFEMP1, anticorps Efemp1
- Sujet
- This gene encodes a member of the fibulin family of extracellular matrix glycoproteins. Like all members of this family, the encoded protein contains tandemly repeated epidermal growth factor-like repeats followed by a C-terminus fibulin-type domain. This gene is upregulated in malignant gliomas and may play a role in the aggressive nature of these tumors. Mutations in this gene are associated with Doyne honeycomb retinal dystrophy. Alternatively spliced transcript variants that encode the same protein have been described.[provided by RefSeq].
- Poids moléculaire
- 52.7 kDa
- ID gène
- 2202
- NCBI Accession
- NM_004105
- HGNC
- 2202
- Pathways
- EGFR Signaling Pathway
-